Fingerprint
Dive into the research topics of 'A phase IB trial of intravenous INO-1001 plus oral temozolomide in subjects with unresectable stage-III or IV melanoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A phase IB trial of intravenous INO-1001 plus oral temozolomide in subjects with unresectable stage-III or IV melanoma
Agop Y. Bedikian, Nicholas E. Papadopoulos, Kevin B. Kim, Wen Jen Hwu, Jade Homsi, Michelle R. Glass, Suzanne Cain, Patrick Rudewicz, Laurent Vernillet, Patrick Hwu
Research output: Contribution to journal › Article › peer-review
68
Scopus
citations